Codes / ICD10CM / M1A.1620

M1A.1620 Lead-induced chronic gout, left knee, without tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lead-Induced Chronic Gout, Left Knee, Without Tophus (Tophi)

Summary

Lead-induced chronic gout is a form of arthritis caused by prolonged lead exposure, leading to persistent joint inflammation and uric acid crystal deposition in the left knee. It is characterized by recurrent episodes of pain and swelling, with the left knee being the specific site affected. Unlike acute gout, this condition persists over time and may involve tissue damage if untreated. The absence of tophi (tophus) indicates no visible nodular deposits of urate crystals in the joint or surrounding tissues.

Causes

This condition results from chronic lead exposure, which disrupts uric acid metabolism and causes crystal accumulation in joints. Lead interferes with renal excretion of uric acid, leading to hyperuricemia and subsequent joint inflammation. Exposure sources include occupational contact, contaminated environments, or historical lead-based products.

Risk Factors

  • Long-term lead exposure (occupational or environmental)
  • Pre-existing hyperuricemia or gout history
  • Male gender
  • Middle-aged or older adults
  • Impaired kidney function

Symptoms

  • Recurrent joint pain, swelling, and tenderness in the left knee
  • Warmth or redness in the affected knee
  • Limited mobility during flare-ups
  • Persistent discomfort between episodes

Diagnosis

Diagnosis combines clinical evaluation, lab tests, and imaging. Blood tests assess uric acid levels, while joint fluid analysis detects urate crystals. Imaging (X-ray, ultrasound) evaluates joint damage and rules out other conditions. Clinical history of lead exposure is critical for differentiation.

Treatment Options

Treatment focuses on reducing lead exposure, managing uric acid levels, and alleviating symptoms. Medications may include urate-lowering agents, anti-inflammatories, or pain relievers. Joint aspiration may be used to reduce swelling during acute flare-ups. Long-term management often involves lifestyle modifications and monitoring.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, but chronic damage may occur if untreated. Regular follow-up monitors uric acid levels, kidney function, and joint health. Early intervention improves outcomes and reduces the risk of complications.

Complications

Untreated or poorly managed cases may lead to joint deformity, chronic pain, or reduced mobility. Persistent hyperuricemia increases the risk of kidney stones or renal impairment over time.

Lifestyle & Prevention

  • Minimize lead exposure by avoiding contaminated environments or occupational hazards.
  • Maintain a balanced diet to support kidney function.
  • Stay hydrated to help excrete uric acid.
  • Follow medical guidance for uric acid-lowering therapy if prescribed.

When to Seek Professional Help

Seek care if symptoms worsen, new joint issues develop, or flare-ups become frequent. Prompt evaluation is needed for severe pain, swelling, or signs of infection. Regular check-ups are recommended for those with known lead exposure or gout history.

Tips for Medical Coders

Use this code for lead-induced chronic gout affecting the left knee without tophus. Document the absence of tophi and specify the left knee as the site. Ensure clinical correlation with lead exposure history and confirm the chronic nature of the condition. Avoid using this code for acute episodes or cases with tophus present.

Book a walkthrough

M1A.1620 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.